CTRI/2020/06/025735尚未招募未知
Perfenidone in Endomyocardial Fibrosis patients
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 发起方
- Rohit Walia
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Endomyocardial Fibrosis patients
- •Informed consent
排除标准
- •Chronic Renal Failure
- •Liver Failure
- •Expected life expectancy less than one year
- •Associated Malignancy
- •Assisted circulation
- •Cardiac devices
- •Contraindications to MRI
研究者
相似试验
尚未招募
不适用
A new drug Pirfenidone used in relieving the stiffness of the mouth caused by tobacco chewingCTRI/2020/03/023844Dr Akshaya S R
招募中
3 期
Pirfenidone in Post COVID lung disease: Randomised controlled studyCTRI/2021/09/036442Sryma PB
已完成
2 期
Pirfenidone and Advanced Liver Fibrosis.Liver FibrosisChronic Liver DiseaseNCT04099407Grupo Mexicano para el Estudios de las Enfermedades Hepaticas122
终止
4 期
The Effects of Eplerenone on Markers of Myocardial Fibrosis in Adult Congenital Heart DiseaseTetralogy of FallotTransposition of the Great Vessels With an Arterial SwitchSingle Ventricle With a Fontan PalliationNCT01971593Washington University School of Medicine26
进行中（未招募）
不适用
Endothelin Receptor Blockade in Heart Failure with Diastolic Dysfunction and Pulmonary Hypertension Randomisierte, placebokontrollierte, multizentrische, doppel- blinde Pilotstudie zur Untersuchung der Wirksamkeit, Sicherheit und Verträglichkeit von Bosentan bei der Behandlung von Pati-enten/innen mit diastolischer Herzinsuffizienz und sekundärer pulmonaler Hypertension (PH) - BADDHYMedDRA version: 9.1Level: LLTClassification code 10000158Term: Abnormal liver function testsHeart failure with normal left ventricle systolic function (HFNEF) are common causes of hospitalisation mainly in the elderly population and are frequently associated with pulmonary hypertension. It is commonly seen, that patients with left heart disease and pulmonary hypertension with right ventricle dysfunction have a worse prognosis. The medical condition to be investigated is HFNEF (Ejection fraction > 50%) and secondary pulmonary hypertension.MedDRA version: 9.1Level: LLTClassification code 10019171Term: Hb decreasedMedDRA version: 9.1Level: LLTClassification code 10005890Term: Body fluid retentionMedDRA version: 9.1Level: LLTClassification code 10019211Term: HeadacheMedDRA version: 9.1Level: LLTClassification code 10040850Term: Skin flushedMedDRA version: 9.1Level: LLTClassification code 10024127Term: Leg edemaMedDRA version: 9.1Level: LLTClassification code 10014264Term: Edematous weight gainMedDRA version: 9.1Level: LLTClassification code 10017884Term: Gastrooesophageal refluxEUCTR2008-005514-40-ATniversitätslehrkrankenhaus Hall in Tirol